Drugs in Context

Medication adherence and treatment-resistant hypertension: a review

Venetoclax: evidence to date and clinical potential

Agents to treat BRAF-mutant lung cancer

Guselkumab for the treatment of psoriasis – evidence to date

New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance

Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues

The therapeutic role of minocycline in Parkinson’s disease

Palbociclib in metastatic breast cancer: current evidence and real-life data

Menopause hormone therapy: latest developments and clinical practice

Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options

Second-line treatment options in hepatocellular carcinoma

Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice

Gastroesophageal reflux in children: an updated review

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges

Challenges and research priorities to progress the impact of antimicrobial stewardship

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?

Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout

Drug therapy for double-hit lymphoma

Anti-NMDA receptor encephalitis: a case study and illness overview

New uses and formulations of glucagon for hypoglycaemia

Mitochondrial disorders and drugs: what every physician should know

Use of botulinum toxin for movement disorders

Novel therapeutic targets for allergic airway disease in children

Therapeutic management of hyperlipoproteinemia (a)

Motion sickness: an overview

Therapy of episodic ataxias: case report and review of the literature

Oral oncolytic and antiretroviral therapy administration: dose adjustments, drug interactions, and other considerations for clinical use

Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research

Immunotherapy in inoperable stage III non-small cell lung cancer: a review

Targeting inducible epigenetic reprogramming pathways in chronic airway remodeling

Targeting eosinophils: severe asthma and beyond

Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease

Neonatal pharmacology and clinical implications

Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature

Standard care and investigational drugs in the treatment of myelofibrosis

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment

The benefits of antimicrobial photodynamic therapy with RLP068 in the management of diabetic foot ulcers

Clinical profile and management of rivaroxaban in patients with atrial fibrillation in routine practice in Spain: data from six nationwide studies

From medications to surgery: advances in the treatment of motor complications in Parkinson’s disease

Hemorrhoid management in women: the role of tribenoside + lidocaine

Immunotherapy in non-melanoma skin cancer: updates and new perspectives

Clinical potential of treatment with semaglutide in type 2 diabetes patients

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system

Clinical trials: their contribution to the efficiency of the clinical management of rheumatoid arthritis

Onset of vitiligo following targeted therapy for BRAFV600E-mutated melanoma: case report